AMBER DRAHL: Open Payments
NPI 1316702046 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 35 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $385 · 2025 $711
Food & beverage: $711
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 11 | $201 |
| Astellas Pharma US Inc | 6 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $91 |
| Sumitomo Pharma America, Inc. | 3 | $62 |
| MILLICENT US INC | 4 | $57 |
| Organon LLC | 2 | $44 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| CONMED Corporation | 1 | $17 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $16 |
Products named: ZURZUVAE, Veozah, Mirena, MYFEMBREE, JADA SYSTEM, FEMLYV, INTRAROSA, Qelbree.
Industry payments across TN — which companies pay providers there.
